AIDS

Brad DeLong delong at econ.Berkeley.EDU
Wed Jan 24 08:06:54 PST 2001



>[lower-priced] generic versions of HIV/AIDS medications from other
>> countries."
>
>So the question is: What's the qualitative difference between the
>low-cost drugs and the expensive ones?

No chemical difference. They have a lower price. They have a lower price because pharmaceutical companies are good at using national borders to segment markets, and good at doing price discrimination.


>Isn't this qualitative difference the least bit suspicious?

No.



More information about the lbo-talk mailing list